Circrisa IV infusion 500mg, manufactured by Sanofi, contains isatuximab (genetical recombination). This injectable drug (YJ code: 4291454A2028) is supplied as 500mg in 25mL per bottle and is indicated for the treatment of multiple myeloma. Note: “Circrisa” is also known as Sarclisa.
Circrisa IV infusion 500mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).